Study on the Health Economic Burden of Alzheimer's Disease in China

Recruiting now

Conditions studied: Alzheimer Disease

In brief

Alzheimer's disease (AD) presents a significant socio-economic challenge globally, with China experiencing a notable rise in its prevalence. This study addresses critical gaps in understanding AD's economic burden and quality of life (QoL) impacts on patients and caregivers in Mainland China.

Key facts

Study ID

NCT05995418

Run by

Xuanwu Hospital, Beijing

People needed

9510

Starts

2023-07-01

Expected to finish

2027-01-01

Last updated by the study team

2026-06-05

Who can join

Age: 40 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Xuanwu Hospital, Capital Medical University — Beijing, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.